Inventor · disambiguated record
Xiaoli Cheng
Also filed as: CHENG XIAOLI
8 granted patents·8 pending applications·146 citations·filing 2008–2024
89Inventor score
Files withPROTAGONIST THERAPEUTICS INC10JANSSEN PHARMACEUTICA NV2TSANN KUEN CHINA ENTPR CO LTD2GUPTA SUNEEL KUMAR1SUNSHINE LAKE PHARMA CO LTD1
Top patents by PatentIndex Score
16 records- 0197US10941183B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·13 cites·20 claims
- 0297US10196424B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·26 cites·22 claims
- 0397US10035824B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·24 cites·26 claims
- 0497US10023614B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 17, 2018·23 cites·21 claims
- 0597US9624268B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·40 cites·24 claims
- 0693US10787490B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Sep 29, 2020·18 cites·18 claims
- 0788US2024199700A1Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0885US11939361B2Compositions of peptide inhibitors of Interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Mar 26, 2024·2 cites·16 claims
- 0976US11884748B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·21 claims
- 1064US2024254180A1Compositions of peptide inhibitors of interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1158US2025179142A1Fusion protein of glp-1 and gdf15 and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1257US2009165657A1Cooking ApplianceTSANN KUEN CHINA ENTPR CO LTD·Filed 2008·Application pending·0 cites
- 1357US2010089379A1GrillTSANN KUEN CHINA ENTPR CO LTD·Filed 2008·Application pending·0 cites
- 1454US2023063321A1Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin AntagonistsGUPTA SUNEEL KUMAR·Filed 2021·Application pending·0 cites
- 1541US2019270786A1Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1635US2020064357A1Methods for determining and monitoring gastrointestinal inflammationPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoli Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →